Faron Pharmaceuticals Oy (LON:FARN - Get Free Report)'s share price passed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of GBX 171.53 ($2.16) and traded as low as GBX 167.70 ($2.11). Faron Pharmaceuticals Oy shares last traded at GBX 167.80 ($2.11), with a volume of 3,575 shares traded.
Faron Pharmaceuticals Oy Trading Down 4.7 %
The company has a 50 day moving average of GBX 170.85 and a two-hundred day moving average of GBX 167.65. The stock has a market capitalization of £169.48 million, a PE ratio of -506.25 and a beta of 0.36. The company has a debt-to-equity ratio of 922.55, a quick ratio of 1.09 and a current ratio of 1.45.
Faron Pharmaceuticals Oy Company Profile
(
Get Free Report)
Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.
Further Reading
Before you consider Faron Pharmaceuticals Oy, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Faron Pharmaceuticals Oy wasn't on the list.
While Faron Pharmaceuticals Oy currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
